AP NEWS

Recro Pharma: 2Q Earnings Snapshot

August 7, 2018

MALVERN, Pa. (AP) _ Recro Pharma Inc. (REPH) on Tuesday reported a loss of $12.7 million in its second quarter.

The Malvern, Pennsylvania-based company said it had a loss of 62 cents per share.

The results surpassed Wall Street expectations. The average estimate of three analysts surveyed by Zacks Investment Research was for a loss of $1.35 per share.

The specialty pharmaceutical company posted revenue of $21.7 million in the period, also exceeding Street forecasts. Three analysts surveyed by Zacks expected $16.8 million.

Recro Pharma shares have dropped 40 percent since the beginning of the year. The stock has fallen 27 percent in the last 12 months.

_____

This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on REPH at https://www.zacks.com/ap/REPH

AP RADIO
Update hourly